Journal of Emergency Health Care
Formerly known as: International Journal of Medical Investigation
Volume 12, Issue 2 (7-2023)
J Emerg Health Care 2023, 12(2): 154-164 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Sahraei R, Ghaedi M, Haghbeen M, Jahromi M S S. Comparison Of Ketamine And Dexmedetomidine In Reducing Complications After Laparoscopic Cholecystectomy Surgery. J Emerg Health Care 2023; 12 (2) :154-164
URL: http://intjmi.com/article-1-1010-en.html
URL: http://intjmi.com/article-1-1010-en.html
Associate Professor of Anesthesiology, Critical care and pain management research center, Jahrom University of Medical Sciences, Jahrom, Iran
Abstract: (1392 Views)
Background: Today, the use of less invasive methods for surgery in the hospital is increasing due to less injuries and complications and faster recovery. One of the most important issues after surgery is to find a drug that can provide the longest period of pain relief and sedation for the patient with minimal side effects. This study was conducted with the aim of comparing ketamine and dexmedetomidine in reducing complications after Laparoscopic Cholecystectomy surgery.
Methods: This study was a double-blind randomized clinical trial. 90 patients were evaluated after Laparoscopic Cholecystectomy surgery. Patients were randomly divided into three control groups, intervention group with ketamine and intervention group with dexmedetomidine. The level of sedation, pain, shivering and nausea and vomiting of the patients after the operation were evaluated.
Result: frequency of patient sedation at the time of entering recovery was significantly different between ketamine, dexmedetomidine and control groups (p=0.006). The comparison of pain in ketamine, dexmedetomidine and control groups showed that the average pain in 15 minutes later, 30 minutes later, 45 minutes later, 60 minutes later, at the time of entering recovery and leaving recovery in the dexmedetomidine group (0%), It was significantly lower than the ketamine and control groups (p<0.001). Comparison of shivering in ketamine, dexmedetomidine and control groups showed that the frequency of shivering at the time of entering recovery in dexmedetomidine group (0%) was significantly lower than ketamine and control groups (p<0.001). frequency of nausea at the time of entering recovery in dexmedetomidine group (0%) was significantly higher than control and ketamine groups (p<0.001).
Conclusion: Based on the results of the present study, the use of dexmedetomidine in Laparoscopic Cholecystectomy surgery causes relaxation, reduces pain and shivering after the operation compared to ketamine. Therefore, this drug can be used as an anesthetic aid in surgery.
Methods: This study was a double-blind randomized clinical trial. 90 patients were evaluated after Laparoscopic Cholecystectomy surgery. Patients were randomly divided into three control groups, intervention group with ketamine and intervention group with dexmedetomidine. The level of sedation, pain, shivering and nausea and vomiting of the patients after the operation were evaluated.
Result: frequency of patient sedation at the time of entering recovery was significantly different between ketamine, dexmedetomidine and control groups (p=0.006). The comparison of pain in ketamine, dexmedetomidine and control groups showed that the average pain in 15 minutes later, 30 minutes later, 45 minutes later, 60 minutes later, at the time of entering recovery and leaving recovery in the dexmedetomidine group (0%), It was significantly lower than the ketamine and control groups (p<0.001). Comparison of shivering in ketamine, dexmedetomidine and control groups showed that the frequency of shivering at the time of entering recovery in dexmedetomidine group (0%) was significantly lower than ketamine and control groups (p<0.001). frequency of nausea at the time of entering recovery in dexmedetomidine group (0%) was significantly higher than control and ketamine groups (p<0.001).
Conclusion: Based on the results of the present study, the use of dexmedetomidine in Laparoscopic Cholecystectomy surgery causes relaxation, reduces pain and shivering after the operation compared to ketamine. Therefore, this drug can be used as an anesthetic aid in surgery.
Keywords: Ketamine, Dexmedetomidine, Laparoscopic Cholecystectomy, Shivering, Pain, Nausea, Vomiting.
References
1. 1. Dubois F, Icard P, Berthelot G, Levard H. Coelioscopic cholecystectomy. Preliminary report of 36 cases. Ann Surg 1990; 211(1): 60-2.
2. Wilhem SM, Dehoome Smith ML, Kale Pradhan PB. Prevention of postoperative nausea and vomiting. Ann Pharmacother 2007; 41: 68-78.
3. Julius D, Basbaum AI. Molecular mechanisms of nociception. Nature. 2001;413(6852):203-10.
4. Maktoobian M, Pazooki SH, Moudir H, Kamali A, Naeemi AR. Comparison of Hemodynamic and Analgesic Effects of Subcutaneous Dexmedetomidine versus Marcaine 0.5% on Herniorrhaphy Scheduled Patients. Journal of Iranian society anesthesiology and intensive care. 2019;106(2): 46-55.
5. Mirkheshti A, Memary E, Nemati Honar B, Jalaeefar A, Sezari P. The efficacy of local dexmedetomidine during fiberoptic nasotracheal intubation: A randomized clinical trial. J Anaesthesiol Clin Pharmacol. 2017 Apr-Jun; 33(2): 209–214.
6. Nazemroaya B, Shafa A, Khizab M. Comparison of the Effect of Ketamine and Sodium Thiopental on Blood Pressure and Heart Rate during Electroconvulsive Therapy in Patients Admitted to the Ward of Psychiatry; A Double-Blind Randomized Clinical Trial. J Isfahan Med Sch 2016; 34(402): 1197-204.
7. Hassani V, Farhadi M, Mohseni M, Safaeian R, Nikoobakht N, Kashani SS, et al. Comparing the Efficacy of Dexmedetomidine versus Fentanyl and Midazolam During Awake Fiberoptic Intubation. Archives of Anesthesiology and Critical Care. 2018;4(4):538-41.
8. Kemp KM, Henderlight L, Neville M. Precedex: Is it the future of cooperative sedation? Nursing 2008; 38: 7-8.
9. Okawa H, Ono T, Hashiba E, Tsuto T, Ishara H, Hirota K. Decreased postoperative nausea and vomiting with dexmedetomidine after off-pump coronary artery bypass grafting. Crit Care 2011; 15: 351.
10. Bhattacharjee DP, Nayek SK, Dawn S, Bandopadhyay G, Gupta K. Effects of dexmedetomidine on hemodynamics in patients undergoing laparoscopic cholecystectomy- A comparative study. J Anesthesia Clin Pharmacol 2010; 26: 45-48.
11. Giovannitti Jr Joseph A, Thoms Sean M, Crawford James J. Alpha-2 adrenergic receptor agonists: a review of current clinical applications. Anesthesia Progress: Spring 2015;62(1):31–8.
12. Khan ZP, Ferguson CN, Jones RM. Alpha-2 and imidazoline receptor agonists. Their pharmacology and therapeutic role. Anaesthesia 1999;54(2):146–65.
13. Munoz R, Berry D. Dexmedetomidine: promising drug for pediatric sedation? Pediatr Crit Care Med 2005;6(4):493–4.
14. Ghaedi M, Sanie S, Sahraei R, Taheri L, Razmavar N. Comparison of ketamine and dexmedetomidine in maintaining hemodynamic stability in laparoscopic cholecystectomy surgery with general anesthesia. Pars Journal of Medical Sciences, 2023; 20(4): 1-7.
15. Berman RM, Cappiello A, Anand A, Oren DA, Heninger GR, Charney DS, et al. Antidepressant effects of ketamine in depressed patients. Biol Psychiatry 2000; 47: 351-354.
16. Singh H, Kundra S, Singh RM, Grewal A, Kaul TK, Sood D. Preemptive analgesia with ketamine for laparoscopic cholecystectomy. J Anaesthesiol Clin Pharmacol 2013; 29: 478.
17. Radvansky BM, Shah K, Parikh A, Sifonios AN, Le V, Eloy JD. Role of ketamine in acute postoperative pain management: a narrative review. Bio Med Res Intern 2015; 2015.
18. Jouguelet-Lacoste J, La Colla L, Schilling D, Chelly JE. The use of intravenous infusion or single dose of lowdose ketamine for postoperative analgesia: a review of the current literature. Pain Med 2015; 16: 383-403.
19. Haji Gholami Saryazdi H, Moradi Farsani D, Hoseini S S, Mahjubipour H. Comparison of the effects of two drug combinations metoclopramide-acetaminophen, and metoclopramide-ketamine on postoperative pain, nausea, and vomiting after deep vitrectomy surgery- A randomized controlled clinical trial. Koomesh 2022; 24 (6) :796-806
20. Nazari, S, Nazari, S, Shayan, A, Shobeiri F, AhmadiNia Tabesh, R. Comparison of the Effects of Ondansetron, Vitamin B6 and Ginger Rhizome in Nausea and Vomiting of Pregnancy: A randomized clinical trial. The Iranian Journal of Obstetrics, Gynecology and Infertility, 2018; 21(7): 29-35.
21. Tosun Z, Akin A, Guler G, Esmaoglu A, Boyaci A. Dexmedetomidine-ketamine and propofol-ketamine combinations for anesthesia in spontaneously breathing pediatric patients undergoing cardiac catheterization. Journal of cardiothoracic and vascular anesthesia. 2006 Aug 1;20(4):515-9.
22. Koruk S, Mizrak A, Gul R, et al: Dexmedetomidine-ketamine and midazolam- ketamine combinations for sedation in pediatric patients undergoing extracorporeal shock wave lithotripsy: A randomized prospective study. J Anesth 2010; 24:858–863
23. Mester R, Easley RB, Brady KM, et al: Monitored anesthesia care with a combination of ketamine and dexmedetomidine dur- ing cardiac catheterization. Am J Ther 2008; 15:24–30
24. Qiu J, Luo Z. The comparison of dexmedetomidine and ketamine for pediatric dental surgery: A meta-analysis of randomized controlled studies. Medicine. 2019 Apr;98(17).
25. Kayyal TA, Wolfswinkel EM, Weathers WM, Capehart SJ, Monson LA, Buchanan EP, Glover CD. Treatment effects of dexmedetomidine and ketamine on postoperative analgesia after cleft palate repair. Craniomaxillofac Trauma Reconstr. 2014 Jun;7(2):131-8.
26. Garg N, Panda NB, Gandhi KA, Bhagat H, Batra YK, Grover VK, Chhabra R. Comparison of small dose ketamine and dexmedetomidine infusion for postoperative analgesia in spine surgery—a prospective randomized double-blind placebo controlled study. Journal of neurosurgical anesthesiology. 2016 Jan 1;28(1):27-31.
27. Chen J Y, Jia J E, Liu T J, Qin M J, Li W X. Comparison of the effects of dexmedetomidine, ketamine, and placebo on emergence agitation after strabismus surgery in children. Can J Anaesth. 2013; 60(4):385–392.
28. Paris A, Tonner PH. Dexmedetomidine in anesthesia. Curr Opin Anaesthesiol 2005; 18: 412-8.
29. Correa-Sales C, Rabin BC, Maze M. A hypnotic response to dexmedetomidine, an alpha 2 agonist, is mediated in the locus ceruleus in rats. Anesthesiology 1992; 76: 948-52.
30. Gaumann DM, Brunet PC, Jirounek P. Clonidine enhances the effects of lidocaine on C-fiber action potential. Anesth Analg 1992; 74: 719-25.
31. Alvarez Corredor FA. Comparison of the effectiveness of dexmedetomidine, meperidine and ketamine in the prevention of postoperative shivering. Rev Esp Anestesiol Reanim. 2016 Nov; 63(9):505-512.
32. Sherif SA, Rehim, Ghada M Aboalfadl, Alaa M Abdelatif. Comparison between dexmedetomidine, ketamine, or dexmedetomidine–ketamine combination for control of shivering during spinal anesthesia. Journal of Current Medical Research and Practice. 2019 Sep 1; 4(3):277.
33. Ameta N, Jacob M, Hasnain S, Ramesh G. Comparison of prophylactic use of ketamine, tramadol, and dexmedetomidine for prevention of shivering after spinal anesthesia. Journal of anesthesiology, clinical pharmacology. 2018 Jul; 34(3):352.
34. Talke P, Tayefeh F, Sessler DI, Jeffrey R, Noursalehi M, Richardson C. Dexmedetomidine does not alter the sweating threshold, but comparably and linearly decreases the vasoconstriction and shivering thresholds. Anesthesiology. 1997; 87:835–41.
35. Martin E, Ramsay G, Mantz J, Sum-Ping STJ. The role of the alpha2-adrenoceptor agonist dexmedetomidine in postsurgical sedation in the intensive care unit. J Intens Care Med 2003; 18:29–41.
36. Dutta S, Lal R, Karol MD, et al. Influence of cardiac output on dexmedetomidine pharmacokinetics. J Pharm Sci 2000; 89: 519–27.
37. Taghinia AH, Shapiro FE, Slavin SA. Dexmedetomidine in aesthetic facial surgery: improving anesthetic safety and efficacy. Plast Reconstr Surg 2008; 121:269–76
38. Nazemroaya B, Honarmand A, Bab Hadi Ashar M. Effects of adding dexmedetomidine to ketamine on heart rate and blood pressure changes in psychiatric patients undergoing electroconvulsive therapy. Koomesh. 2020; 22 (2):311-316
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |